The informed consent process should explain the study risks and benefits fully and clearly in terms of what is known, what is uncertain and what is unknown.

During pandemics, it may be a challenge to explain the risks of research to research participants, because there may be more risks that are yet unknown, or the level of risk is uncertain. This needs to be conveyed to research participants in a careful manner.